LINK NAAR EEN VAN ONZE 41 LIDSTATEN VOOR LOKALE ONDERSTEUNING, ADVIES EN NIEUWS

bekijk kaart
Sluit
  • Finland
  • Norway
  • Sweden
  • Estonia
  • Russian Federation
  • Latvia
  • Denmark
  • Lithuania
  • United Kingdom
  • Netherlands
  • Ireland
  • Poland
  • Germany
  • Belgium
  • Czech Republic
  • Ukraine
  • Slovakia
  • Luxembourg
  • Moldova, Republic of
  • Austria
  • France
  • Switzerland
  • Romania
  • Slovenia
  • Croatia
  • Serbia
  • Bosnia & Herzegovina
  • Bulgaria
  • Italy
  • Macedonia, the Former Yugoslav Republic of
  • Spain
  • Greece
  • Israel

AVROBIO Announces Clinical and Regulatory Progress For Gaucher Disease Program

15 January 2020

AVROBIO has announced that it has received notice of clearance from the FDA regarding an Investigational New Drug (IND) application for AVR-RD-02, its investigational gene therapy for the treatment of Gaucher disease and has received consent from the first patient to enroll in its global Phase 1/2 trial.

The GAU-201 trial is actively recruiting in Australia and Canada, with additional sites planned in the United States.

 

Full press release can be found here